AU2011904913A0 - Compositions and methods for modulating uterine contractions - Google Patents

Compositions and methods for modulating uterine contractions

Info

Publication number
AU2011904913A0
AU2011904913A0 AU2011904913A AU2011904913A AU2011904913A0 AU 2011904913 A0 AU2011904913 A0 AU 2011904913A0 AU 2011904913 A AU2011904913 A AU 2011904913A AU 2011904913 A AU2011904913 A AU 2011904913A AU 2011904913 A0 AU2011904913 A0 AU 2011904913A0
Authority
AU
Australia
Prior art keywords
compositions
methods
uterine contractions
modulating
modulating uterine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2011904913A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Newcastle Innovation Ltd
Original Assignee
Newcastle Innovation Ltd
Filing date
Publication date
Application filed by Newcastle Innovation Ltd filed Critical Newcastle Innovation Ltd
Publication of AU2011904913A0 publication Critical patent/AU2011904913A0/en
Priority to PCT/AU2012/001446 priority Critical patent/WO2013075176A1/en
Abandoned legal-status Critical Current

Links

AU2011904913A 2011-11-24 2011-11-24 Compositions and methods for modulating uterine contractions Abandoned AU2011904913A0 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
PCT/AU2012/001446 WO2013075176A1 (en) 2011-11-24 2012-11-23 Compositions and methods for modulating uterine contractions

Publications (1)

Publication Number Publication Date
AU2011904913A0 true AU2011904913A0 (en) 2011-12-08

Family

ID=

Similar Documents

Publication Publication Date Title
AP3414A (en) Compositions and methods for modulating fxr
IL226196A0 (en) Methods and compositions for modulating pd1
EP2850189B8 (en) Compositions and methods for modulating gene expression
ZA201502884B (en) Compositions and methods for modulating cell signaling
EP3033424A4 (en) Compositions and methods for modulating rna
EP2569429A4 (en) Compositions and methods for modulating metabolism
ZA201300319B (en) Compositions and methods for modulating the wnt signaling pathway
EP2665486A4 (en) Compositions and mehthods for modulating gamma-c-cytokine activity
EP2571530A4 (en) Methods and compositions related to modulating autophagy
EP2760887A4 (en) Compositions and methods for modulating hemostasis
EP2773358A4 (en) Compositions and methods for hemostasis
IL225391A0 (en) Methods and compositions for modulating the wnt pathway
WO2011109768A9 (en) Compositions and methods for modulating cardiac conditions
HRP20160879T1 (en) Compositions and methods for modulating a kinase
EP2611902A4 (en) Compositions and methods for modulating emt and uses thereof
PL2583431T3 (en) Procedure for commercial communications
AU2011904913A0 (en) Compositions and methods for modulating uterine contractions
ME02797B (en) Compositions and methods for modulating fxr
EP2766036A4 (en) Compositions and methods for modulating thrombin generation
AU2010903691A0 (en) Coupler
AU2010904350A0 (en) GGG Train
AU2011903876A0 (en) GGG Train
AU2012904042A0 (en) GGG Train
AU2010905016A0 (en) Closure
AU2011903938A0 (en) Therapeutic methods and compositions